Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicity

Biomedicine and Pharmacotherapy

Volumn 63, Issue 2, 2009, Pages 79-85

  Townsend, Danyelle M ^a   Tew, Kenneth D ^b   He, Lin ^a   King, Jarrod B ^c   Hanigan, Marie H ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Bone marrow toxicity; Chemotherapy; Cisplatin; Glutathione S transferase Pi; Nephrotoxicity

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; CISPLATIN; CYSTEINE CONJUGATE BETA LYASE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; MICROSOMAL AMINOPEPTIDASE; PLATINUM; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA ADDUCT; DRUG CONJUGATION; DRUG METABOLISM; ENZYME MODIFICATION; FEMALE; GENE; GENE EXPRESSION; GSTP GENE; HISTOLOGY; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; LIVER; MALE; MOUSE; NEPHROTOXICITY; NEWBORN; NONHUMAN; OUTCOME ASSESSMENT; OXIDATION REDUCTION REACTION; PHARMACOGENETICS; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN CARCINOGENESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBON-SULFUR LYASES; CISPLATIN; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE S-TRANSFERASE PI; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 58949095799     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.08.004     Document Type: Article

References (39)

1. Zamble D.B., and Lippard S.J. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci 20 (1995) 435-439
2. Anders M.W., and Dekant W. Glutathione-dependent bioactivation of haloalkenes. Annu Rev Pharmacol Toxicol 38 (1998) 501-537
3. Dekant W. Bioactivation of nephrotoxins and renal carcinogens by glutathione S-conjugate formation. Toxicol Lett 67 (1993) 151-160
4. Kanhai W., Dekant W., and Henschler D. Metabolism of the nephrotoxin dichloroacetylene by glutathione conjugation. Chem Res Toxicol 2 (1989) 51-56
5. Kramer R.A., Foureman G., Greene K.E., and Reed D.J. Nephrotoxicity of S-(2-chloroethyl)glutathione in the Fischer rat: evidence for gamma-glutamyltranspeptidase-independent uptake by the kidney. J Pharmacol Exp Ther 242 (1987) 741-748
6. Jaffe D.R. In vivo and in vitro nephrotoxicity of the cysteine conjugate of hexachlorobutadiene. J Toxicol Environ Health 11 (1983) 857-863
7. Hanigan M.H., Gallagher B.C., Taylor Jr. P.T., and Large M.K. Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Res 54 (1994) 5925-5929
8. Hanigan M.H., Lykissa E.D., Townsend D.M., Ou C.N., Barrios R., and Lieberman M.W. Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin. Am J Pathol 159 (2001) 1889-1894
9. Townsend D.M., Deng M., Zhang L., Lapus M.G., and Hanigan M.H. Metabolism of cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 14 (2003) 1-10
10. Townsend D.M., and Hanigan M.H. Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice. J Pharmacol Exp Ther 300 (2002) 142-148
11. Townsend D.M., Marto J.A., Deng M., Macdonald T.J., and Hanigan M.H. High pressure liquid chromatography and mass spectrometry characterization of the nephrotoxic biotransformation products of cisplatin. Drug Metab Dispos 31 (2003) 705-713
12. Ishikawa T., Bao J.J., Yamane Y., Akimaru K., Frindrich K., Wright C.D., et al. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells. J Biol Chem 271 (1996) 14981-14988
13. Miyazaki M., Kohno K., Saburi Y., Matsuo K., Ono M., Kuwano M., et al. Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase Pi gene. Biochem Biophys Res Commun 166 (1990) 1358-1364
14. Nakagawa K., Yokota J., Wada M., Sasaki Y., Fujiwara Y., Sakai M., et al. Levels of glutathione S-transferase pi mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin. Jpn J Cancer Res 79 (1988) 301-304
15. Townsend D.M., Shen H., Staros A.L., Gate L., and Tew K.D. Efficacy of a glutathione S-transferase pi-activated prodrug in platinum-resistant ovarian cancer cells. Mol Cancer Ther 1 (2002) 1089-1095
16. Nishimura T., Newkirk K., Sessions R.B., Andrews P.A., Trock B.J., Rusmussen A.A., et al. Association between expression of glutathione-associated enzymes and response to platinum-based chemotherapy in head and neck cancer. Chem Biol Interact 111-112 (1998) 187-198
17. Hayes J.D., and Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30 (1995) 445-600
18. Henderson C.J., Wolf C.R., Kitteringham N., Powell H., Otto D., and Park B.K. Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proc Natl Acad Sci U S A 97 (2000) 12741-12745
19. Henderson C.J., Smith A.G., Ure J., Brown K., Bacon E.J., and Wolf C.R. Increased skin tumorigenesis in mice lacking Pi class glutathione S-transferases. Proc Natl Acad Sci U S A 95 (1998) 5275-5280
20. Gate L., Majumdar R.S., Lunk A., and Tew K.D. Influence of glutathione S-transferase Pi and p53 expression on tumor frequency and spectrum in mice. Int J Cancer 113 (2005) 29-35
21. Bammler T.K., Smith C.A., and Wolf C.R. Isolation and characterization of two mouse Pi-class glutathione S-transferase genes. Biochem J 298 Pt. 2 (1994) 385-390
22. Glantz S.A. Primer of bio-statics. 3 ed. (1992), McGraw-Hill Inc., New York
23. Chary K.K., Higby D.J., Henderson E.S., and Swinerton K.D. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis. Cancer Treat Rep 61 (1977) 367-370
24. Knight T.R., Choudhuri S., and Klaassen C.D. Constitutive mRNA expression of various glutathione S-transferase isoforms in different tissues of mice. Toxicol Sci 100 (2007) 513-524
25. Anders M.W. Chemical toxicology of reactive intermediates formed by the glutathione-dependent bioactivation of halogen-containing compounds. Chem Res Toxicol 21 (2008) 145-159
26. Dekant W., Vamvakas S., and Anders M.W. Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate beta-lyase pathway. In: Anders M.W., and Dekant W. (Eds). Advances in pharmacology vol. 27 (1994), Academic Press Inc., New York 115-162
27. Daley-Yates P.T., and McBrien D.C.H. Cisplatin metabolites in plasma: a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatin. Biochem Pharmacol 33 (1984) 3063-3070
28. Hanigan M.H., Gallagher B.C., and Taylor Jr. P.T. Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney. Am J Obstet Gynecol 175 (1996) 270-274
29. Ruscoe J.E., Rosario L.A., Wang T., Gate L., Arifoglu P., Wolf C.R., et al. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 298 (2001) 339-345
30. Ishimoto T.M., and Ali-Osman F. Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli. Pharmacogenetics 12 (2002) 543-553
31. Townsend D.M., and Tew K.D. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22 (2003) 7369-7375
32. Lo H.W., and Ali-Osman F. Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr Opin Pharmacol 7 (2007) 367-374
33. Zhao G., and Wang X. Advance in antitumour agents targeting glutathione-S-transferase. Curr Med Chem 13 (2006) 1461-1471
34. Tew K.D., Bomber A.M., and Hoffman S.J. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res 48 (1988) 3622-3625
35. O'Dwyer P.J., LaCreta F., Nash S., Tinsley P.W., Schilder R., Clapper M.L., et al. Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid. Cancer Res 51 (1991) 6059-6065
36. LaCreta F.P., Brennan J.M., Nash S.L., Comis R.L., Tew K.D., and O'Dwyer P.J. Pharmacokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancer. J Pharmacol Exp Ther 270 (1994) 1186-1191
37. Wang R., Li C., Song D., Zhao G., Zhao L., and Jing Y. Ethacrynic acid butyl-ester induces apoptosis in leukemia cells through a hydrogen peroxide mediated pathway independent of glutathione S-transferase P1-1 inhibition. Cancer Res 67 (2007) 7856-7864
38. Townsend D., and Tew K. Cancer drugs, genetic variation and the glutathione-S-transferase gene family. Am J Pharmacogenomics 3 (2003) 157-172
39. Lash L.H., Qian W., Putt D.A., Jacobs K., Elfarra A.A., Krause R.J., and Parker J.C. Glutathione conjugation of trichloroethylene in rats and mice:sex-, species-, and tissue-dependent differences. Drug Metab Dispos 26 (1998) 12-19